StockData
Curative Biotechnology Inc logo

Curative Biotechnology Inc (CUBT) stock

CUBTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.91−0.00 (-0.01%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal

Valuation

Market cap
–
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Trading

Previous close
$0.91
Open
$0.70
Day's range
$0.70 – $0.91
Volume
300
Average volume (20 days)
1,651

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodCUBTS&P 500DifferenceCUBT per yearS&P 500 per year
1 month-9.1%+0.6%−9.7 pts
3 months-9.1%+3.4%−12.4 pts
Year to date+12.3%+13.3%−1.0 pts
1 year-22.3%+16.6%−38.9 pts
3 years-40.6%+86.4%−126.9 pts-15.9%+23.1%
5 years-94.2%+81.9%−176.0 pts-43.4%+12.7%
10 years+2931.1%+318.9%+2612.2 pts+40.7%+15.4%

Curative Biotechnology stock: common questions

What is Curative Biotechnology's stock price?

CUBT closed at $0.91 on Oct 19, 2026, down 0.01% on the day.

Does Curative Biotechnology pay a dividend?

No. Curative Biotechnology has not paid a cash dividend over the last twelve months.

How has CUBT stock performed over the past year?

Including dividends, CUBT returned -22.3% over the past year, against +16.6% for the S&P 500.

Who are Curative Biotechnology's competitors?

Companies most similar to Curative Biotechnology by business, industry and size include AMGN, GILD, MRNA, BIIB, BNTX.

See a number that looks wrong?